U.S. markets closed
  • S&P Futures

    4,411.00
    -3.25 (-0.07%)
     
  • Dow Futures

    34,994.00
    -40.00 (-0.11%)
     
  • Nasdaq Futures

    15,112.00
    -5.75 (-0.04%)
     
  • Russell 2000 Futures

    2,209.30
    -4.10 (-0.19%)
     
  • Crude Oil

    72.09
    +0.18 (+0.25%)
     
  • Gold

    1,797.30
    -1.90 (-0.11%)
     
  • Silver

    25.19
    -0.12 (-0.49%)
     
  • EUR/USD

    1.1815
    +0.0007 (+0.06%)
     
  • 10-Yr Bond

    1.2760
    -0.0100 (-0.78%)
     
  • Vix

    17.58
    +0.38 (+2.21%)
     
  • GBP/USD

    1.3832
    +0.0008 (+0.06%)
     
  • USD/JPY

    110.2400
    -0.1350 (-0.12%)
     
  • BTC-USD

    37,223.37
    +1,581.80 (+4.44%)
     
  • CMC Crypto 200

    883.07
    -32.42 (-3.54%)
     
  • FTSE 100

    7,025.43
    -2.15 (-0.03%)
     
  • Nikkei 225

    27,886.43
    +53.14 (+0.19%)
     

Is a Surprise Coming for Catalyst Biosciences (CBIO) This Earnings Season?

·2 min read

Investors are always looking for stocks that are poised to beat at earnings season and Catalyst Biosciences, Inc. CBIO may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because Catalyst Biosciences is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for CBIO in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 67 cents per share for CBIO, compared to a broader Zacks Consensus Estimate of a loss of 77 cents per share. This suggests that analysts have very recently bumped up their estimates for CBIO, giving the stock a Zacks Earnings ESP of +13.64% heading into earnings season.

Catalyst Biosciences, Inc. Price and EPS Surprise

Catalyst Biosciences, Inc. Price and EPS Surprise
Catalyst Biosciences, Inc. Price and EPS Surprise

Catalyst Biosciences, Inc. price-eps-surprise | Catalyst Biosciences, Inc. Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that CBIO has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for Catalyst Biosciences, and that a beat might be in the cards for the upcoming report.

Zacks Top 10 Stocks for 2021

In addition to the stocks discussed above, would you like to know about our 10 best buy-and-hold tickers for the entirety of 2021?

Last year's 2020 Zacks Top 10 Stocks portfolio returned gains as high as +386.8%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2021 today >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Catalyst Biosciences, Inc. (CBIO) : Free Stock Analysis Report

To read this article on Zacks.com click here.